Cleared Traditional

K964580 - CAP-AID (IMPROVED)

K964580 is an FDA 510(k) clearance for CAP-AID (IMPROVED), manufactured by Nebel, Inc.. The device is a Class 1 Gastroenterology & Urology device with product code FHA cleared through the Traditional 510(k) pathway after a 56-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1997
Decision
56d
Days
Class 1
Risk

K964580 is an FDA 510(k) clearance for the CAP-AID (IMPROVED). Classified as Clamp, Penile (product code FHA), Class I - General Controls.

Submitted by Nebel, Inc. (Worcester, US). The FDA issued a Cleared decision on January 10, 1997 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5160 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nebel, Inc. devices

FDA 510(k) Submission Details - K964580

510(k) Number K964580 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 15, 1996
Decision Date January 10, 1997
Days to Decision 56 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 130d · This submission: 56d
Pathway characteristics
Predicate-based equivalence.

FHA Device Classification - Class 1, General Controls

Product Code FHA Clamp, Penile
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 876.5160
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.